Company:  NEOGENOMICS INC (NEO)
Form Type:  4
Filing Date:  6/1/2020 
CIK:  0001077183 
Address:  12701 COMMONWEALTH DRIVE
SUITE 9
 
City, State, Zip:  FORT MYERS, Florida 33913 
Telephone:  (941) 923-1949 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$36.16  
Change: 
0.34 (0.95%)  
Trade Time: 
Sep 28  
Market Cap: 
$3.99B
Trade NEO now with

© 2020  
Description of Business
NeoGenomics, Inc., a Nevada corporation (referred to individually as the "Parent Company" or collectively with its subsidiaries as "NeoGenomics", "we", "us", "our" or the "Company" in this Annual Report) is the registrant for SEC reporting purposes. Our common stock is listed on the NASDAQ Capital Market under the symbol "NEO". Overview We operate a network of cancer-focused testing laboratories in the United States as well as laboratories in Switzerland and Singapore. Our mission is to improve patient care through exceptional cancer-focused testing services. Our vision is to be the World's leading cancer testing and information company by delivering uncompromising quality and innovative solutions while providing exceptional service and operating with a world-class culture.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    REPORTING OWNERS
    SIGNATURES